A rapid troponin I assay is not optimal for determination of troponin status and prediction of subsequent cardiac events at suspicion of unstable coronary syndromes

This publication has 24 references indexed in Scilit:

• Troponin and C-reactive protein have different relations to subsequent mortality and myocardial infarction after acute coronary syndrome
  Journal of the American College of Cardiology, 2003
• Effect of glycoprotein IIb/IIIa receptor blocker abciximab on outcome in patients with acute coronary syndromes without early coronary revascularisation: the GUSTO IV-ACS randomised trial
  The Lancet, 2001
• Comparison between strategies using creatine kinase-MB(mass), myoglobin, and troponin T in the early detection or exclusion of acute myocardial infarction in patients with chest pain and a nondiagnostic electrocardiogra
  The American Journal of Cardiology, 2000
• Management of acute coronary syndromes: acute coronary syndromes without persistent ST segment elevation. Recommendations of the Task Force of the European Society of Cardiology Recommendations of the Task Force of the European Society of Cardiology
  European Heart Journal, 2000
• Time-dependent diagnostic performance of a rapid troponin T version 2 bedside test in patients with acute coronary syndromes
  Scandinavian Journal of Clinical and Laboratory Investigation, 2000
• Benefit of Abciximab in Patients with Refractory Unstable Angina in Relation to Serum Troponin T Levels
  New England Journal of Medicine, 1999
• Cardiac-Specific Troponin I Levels to Predict the Risk of Mortality in Patients with Acute Coronary Syndromes
  New England Journal of Medicine, 1996
• Value of Myoglobin, Troponin T, and CK-MB _mass in Ruling Out an Acute Myocardial Infarction in the Emergency Room
  Circulation, 1995
• Failure of new biochemical markers to exclude acute myocardial infarction at admission
  The Lancet, 1993
• The Prognostic Value of Serum Troponin T in Unstable Angina
  New England Journal of Medicine, 1992